Literature DB >> 8321321

Protein kinase C alpha activates RAF-1 by direct phosphorylation.

W Kolch1, G Heidecker, G Kochs, R Hummel, H Vahidi, H Mischak, G Finkenzeller, D Marmé, U R Rapp.   

Abstract

The kinase Raf-1 can be activated by treatment of cells with mitogens and by the protein kinase C (PKC) activator 12-O-tetradecanoyl-phorbol-13-acetate (TPA) (reviewed in refs 1,2). Activated Raf-1 triggers a protein kinase cascade by direct phosphorylation of MAP kinase kinase, resulting in phosphorylation of ternary complex factor and Jun by MAP kinase. Here we investigate the molecular mechanism and biological consequences of PKC alpha-mediated Raf-1 activation in NIH3T3 fibroblasts. PKC alpha directly phosphorylates and activates Raf-1 both in vitro and in vivo. PKC alpha induces Raf-1 phosphorylation at several sites, including a serine residue at position 499. Mutation of serine at this position or at residue 259 does not abrogate Raf-1 stimulation by a combination of Ras plus the src tyrosine kinase Lck, but severely impedes Raf-1 activation by PKC alpha. Consistent with such a direct interaction is the observation that Raf-1 and PKC alpha cooperate in the transformation of NIH3T3 cells. The Ser499 phosphorylation site is necessary for this synergism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321321     DOI: 10.1038/364249a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  280 in total

1.  Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation.

Authors:  A Adomeit; A Graness; S Gross; K Seedorf; R Wetzker; C Liebmann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.

Authors:  D H Wolf; S Numan; E J Nestler; D S Russell
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

3.  Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.

Authors:  C S Mason; C J Springer; R G Cooper; G Superti-Furga; C J Marshall; R Marais
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 4.  Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis.

Authors:  B L Webb; S J Hirst; M A Giembycz
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 5.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 6.  Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Authors:  Mariana M Belcheva; Carmine J Coscia
Journal:  Neurosignals       Date:  2002 Jan-Feb

7.  Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.

Authors:  M T Yip-Schneider; W Miao; A Lin; D S Barnard; G Tzivion; M S Marshall
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

8.  Localization of phospholipase D1 to caveolin-enriched membrane via palmitoylation: implications for epidermal growth factor signaling.

Authors:  Jung Min Han; Yong Kim; Jun Sung Lee; Chang Sup Lee; Byoung Dae Lee; Motoi Ohba; Toshio Kuroki; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

Review 9.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

10.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.